Professional Documents
Culture Documents
Page 1 of 6
Vijaya Diagnostic Centre
16-11-741/C/C, Beside TITAN Showroom, Dilsukhnagar, Hyderabad.
Email : info@vijayadiagnostic.com
Pregnancy :
-----------------
First Trimester : 0.81-1.9 ng/mL
Second Trimester : 1.0-2.6 ng/mL
Third Trimester : 1.0-2.6 ng/mL
Method : Chemiluminescence Immuno Assay (CLIA)
Pregnancy :
---------------
First Trimester : 0.3-4.5 µIU/mL
Second Trimester: 0.5-4.6 µIU/mL
Third Trimester : 0.8-5.2 µIU/mL
Method : Chemiluminescence Immuno Assay (CLIA)
Comments / Interpretation :
---------------------------------
- Patient preparation is particularly important for hormone studies, results of which may be markedly affected by
many factors such as stress, position, fasting state, time of the day, preceding diet and drug therapy.
- The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hyperthyroidism.
- T3 is not recommended for diagnosis of hypothyroidism as decreased values have minimal clinical significance.
- Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic
stress and hypothyroidism.
- Elevated level of T4 are seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum Thyroxine Binding
Globulin.
- Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in Thyroxine Binding
Globulin.
- TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos
thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium and iodine induced or deficiency
goiter.
- Decreased levels of TSH may be seen in Graves Disease, Toxic multinodular Goitre, Thyroiditis, Excessive treatment
with thyroid hormone replacement and central Hypothyroidism.
DR R ANITHA
CONSULTANT BIOCHEMIST
Page 2 of 6
Vijaya Diagnostic Centre
16-11-741/C/C, Beside TITAN Showroom, Dilsukhnagar, Hyderabad.
Email : info@vijayadiagnostic.com
MCH : 19.90 27 - 32 pg
Calculated
Neutrophils : 68 40 - 80 %
VCSn Technology & Microscopy
Lymphocytes : 27 20 - 40 %
VCSn Technology & Microscopy
Eosinophils : 1 1-6 %
VCSn Technology & Microscopy
Monocytes : 4 2 - 10 %
VCSn Technology & Microscopy
Basophils : 0 0-2 %
VCSn Technology & Microscopy
Absolute Leucocyte Count
DR.PAVANI B
CONSULTANT PATHOLOGIST
Page 4 of 6
Vijaya Diagnostic Centre
16-11-741/C/C, Beside TITAN Showroom, Dilsukhnagar, Hyderabad.
Email : info@vijayadiagnostic.com
Urobilinogen : Normal NA
Modified Ehrlich reaction
DR.VAISHNAVI
CONSULTANT PATHOLOGIST
Page 5 of 6
Vijaya Diagnostic Centre
16-11-741/C/C, Beside TITAN Showroom, Dilsukhnagar, Hyderabad.
Email : info@vijayadiagnostic.com
DR.PAVANI B
CONSULTANT PATHOLOGIST
Page 6 of 6
Vijaya Diagnostic Centre
3-6-16 & 17, Street No. 19, Himayatnagar, Hyderabad - 500 029
Helpline : 040-21000000
Email : info@vijayadiagnostic.com
www.vijayadiagnostic.com
Comments :
1). Culture results should ALWAYS be correlated with clinical symptoms and microscopy.
2). Sterile pyuria (with pus cells & no growth ) - Rule out H/o prior antibiotic therapy,
urethritis, prostatitis, renal calculi, renal tuberculosis, catheterisation etc.,
3). Asymptomatic bacteriuria (bacteria in Urine without symptoms) is common in pregnancy / elderly patients.
4). AST for Colistin has to be confirmed with BMD method as per CLSI M 100 guidelines
Note : -
Email : info@vijayadiagnostic.com
www.vijayadiagnostic.com
Comments / Interpretation :
---------------------------------
- Glycosylated hemoglobin is proportional to mean plasma glucose level during previous 6-12 weeks.
- Values may not be comparable with different methodologies and even different laboratories using the same methodology.
- Perform A1c at least twice annually in Diabetes patients to ascertain meeting of goals
- Perform A1c test quarterly in Diabetes patients whose therapy has changed and who are not meeting goals
- Recommended goal of A1c is < 7%
- ADA Guidelines 2019.
Email : info@vijayadiagnostic.com
www.vijayadiagnostic.com
20.0
17.5
15.0
12.5
%A1c
10.0
0.53
0.81
7.5
A1c -
0.42
-
0.23
0.89
5.0
0.16
-
-
-
-
2.5
1.02
0.0
-